XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Net revenues $ 39,552,507 $ 42,010,949
Costs and expenses:    
Cost of products sold 6,066,611 9,118,521
Selling and marketing 18,451,765 16,660,945
Research and development 5,834,229 6,688,924
General and administrative 10,651,915 10,180,120
Amortization and impairment 8,102,648 5,067,368
Total costs and expenses 49,107,168 47,715,878
Operating loss (9,554,661) (5,704,929)
Interest income 286,854 98,405
Other income 2,828,871 0
Other income - settlement 475,000 0
Other income - gain on insurance proceeds 346,800 611,330
Interest expense (667,861) (585,995)
Loss before income taxes (6,284,997) (5,581,189)
Income tax expense (45,769) (68,850)
Net loss (6,330,766) (5,650,039)
Net loss at subsidiary attributable to noncontrolling interests 51,446 79,798
Net loss attributable to common shareholders $ (6,279,320) $ (5,570,241)
Loss per share attributable to common shareholders:    
Basic (in USD per share) $ (0.44) $ (0.38)
Diluted (in USD per share) $ (0.44) $ (0.38)
Weighted-average shares outstanding    
Basic (in shares) 14,298,774 14,563,592
Diluted (in shares) 14,298,774 14,563,592
Product    
Net revenues $ 37,513,492 $ 40,681,182
Other    
Net revenues $ 2,039,015 $ 1,329,767